Live Breaking News & Updates on Oren Becher

Stay updated with breaking news from Oren becher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Late-toxicity burden high among survivors of high-risk neuroblastoma

CHICAGO — Survivors of high-risk neuroblastoma face a substantial burden of late toxicity, according to study results presented at ASCO Annual Meeting.Prevalence of some late effects vary by treatment received, findings showed. ....

University Of Chicago , United States , Tarao Henderson , Bymark Leiser , Oren Becher , Mindy Valcarcel , Chidlren Oncology Group , National Academies Of Medicine , Sciences Committee On Disability , National Academies , Sciences Committee , Young Adult Survivorship Center , Oncology Group , Oncology Group Based ,

Combination therapy shows preliminary antitumor activity in pediatric neuroblastoma

The combination of olaparib and the investigational ATR inhibitor ceralasertib induced antitumor responses in children and adolescents with DNA repair-deficient tumors, according to phase 1 results of the AcSĂ©-ESMART trial.The data, presented at American Association for Cancer Research Annual Meeting, also showed ceralasertib (AZD6738, AstraZeneca) plus olaparib (Lynparza, AstraZeneca) — a ....

United States , United Kingdom , Susanne Gatz , Oren Becher , Mindy Valcarcel , Timothy Yap , Fondation Gustave Roussy , Bydrew Amorosi , Cancer Research United Kingdom , Leukaemia Group , Genomic Sciences , French Institut National De Cancer , University Of Birmingham Institute Cancer , American Association For Cancer Research Annual Meeting , Little Princess Trust Children Cancer , American Association , Cancer Research Annual Meeting , Astrazeneca France , Little Princess , Adobe Stock , Europe Based Acs ,